Concepedia

Mark Savage

MS

3

Publications

54

Citations

3

H-Index

2003

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Mark Savage is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and drug development.

Top concepts

Publications per year

2003–2011

3

Publications

3

The use of 96-well Scintiplates to facilitate definitive metabolism studies for drug candidates

Angus N. R. Nedderman, Mark Savage, Katharine L White et al. · Journal of Pharmaceutical and Biomedical Analysis · 2003 · 28 citations

, , +12

A sensitive HPLC-MS-MS assay for quantitative determination of midazolam in dog plasma

Simon R. Harris, J. I. Gedge, Angus N. R. Nedderman et al. · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 13 citations

, , +7

Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms

Anthony Harrison, Iain Gardner, Tanya Hay et al. · Xenobiotica · 2011 · 13 citations

Rows per page

1–3 of 3